Sumitomo Pharma Co Ltd (STU:DPM)
€ 3.66 -0.1 (-2.66%) Market Cap: 1.50 Bil Enterprise Value: 3.90 Bil PE Ratio: 0 PB Ratio: 1.53 GF Score: 59/100

Q1 2022 Sumitomo Dainippon Pharma Co Ltd Earnings Call Transcript

Jul 29, 2021 / NTS GMT
Release Date Price: €16 (-3.03%)
Hiroshi Nomura
Sumitomo Dainippon Pharma Co., Ltd. - CEO, President & Representative Director

My name is Hiroshi Nomura. I'm the President and CEO of Sumitomo Dainippon Pharma. Thank you for taking your time to join the conference call for the first quarter. I would like to thank you for your continued interest in our company. Your comments and feedback are helpful in managing our company.

We published the financial results today. I personally wanted to be here to take your questions because I'm sure you have questions for me to explain the significant gaps in the results when you compare with the same period of last year, what was the forecast.

First, Mr. Kashima will go over the presentation.

Hisayoshi Kashima
Sumitomo Dainippon Pharma Co., Ltd. - Senior Director & Corporate Controller

Please look at Slide 3. I would like to present the financial results for the quarter on IFRS core basis. The revenues were JPY 131.2 billion, down by JPY 2.7 billion from the same period of last year. Although China segment increased revenues, Japan

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot